Compare RLMD & LDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RLMD | LDI |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.9M | 542.4M |
| IPO Year | 2012 | 2021 |
| Metric | RLMD | LDI |
|---|---|---|
| Price | $3.51 | $0.60 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 4 | 4 |
| Target Price | ★ $10.75 | $1.13 |
| AVG Volume (30 Days) | 1.3M | ★ 7.1M |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,070.00 | N/A |
| Revenue This Year | N/A | $3.11 |
| Revenue Next Year | N/A | $9.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $1.80 | $0.57 |
| 52 Week High | $8.00 | $3.80 |
| Indicator | RLMD | LDI |
|---|---|---|
| Relative Strength Index (RSI) | 26.78 | 30.36 |
| Support Level | $3.22 | N/A |
| Resistance Level | $4.44 | $1.19 |
| Average True Range (ATR) | 0.20 | 0.05 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 5.18 | 12.25 |
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.